WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke mRNACT wurde als Wortmarke am 28.10.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1660204 |
| Länder | 
|
| Basismarke |
Nr. 90720622,
19. Mai 2021
|
| Anmeldedatum | 28. Oktober 2021 |
| Ablaufdatum | 28. Oktober 2031 |
Markeninhaber
475 Green Oaks Parkway
Holly Springs NC 27540
US
Holly Springs NC 27540
US
Markenvertreter
151 West 42nd Street, 17th Floor
New York NY 10036
US
Waren und Dienstleistungen
01
Medical, biological, and pharmaceutical preparations for
scientific and research use, or for the manufacture of
pharmaceuticals, namely, preparations containing messenger
RNA for preventing and treating viruses and respiratory
disorders; biochemicals for in vivo, ex vivo, on vivo or in
vitro scientific research and medical research, namely, for
use in the manufacture of pharmaceuticals for preventing and
treating viruses and respiratory disorders; lipid
nanoparticles for scientific, laboratory or medical research
use
05
Vaccines; vaccine adjuvants; medical, biological, and
pharmaceutical preparations for medical use, namely,
preparations containing messenger RNA for preventing and
treating viruses and respiratory disorders; mRNA-based
therapeutics and therapeutic agents for in vivo, ex vivo, or
in situ prevention and treatment of viruses and respiratory
disorders; lipid nanoparticles for pharmaceutical, medical
or diagnostic purposes; drug carriers for medical use,
namely, lipid nanoparticles for delivering drugs; lipid
nanoparticles for drug delivery sold as an integral
component of drugs; pharmaceutical preparations, namely,
messenger RNA and delivery agents comprised of lipid
nanoparticle carriers and polymers for the delivery of mRNA
to human cells; medical, biological, and pharmaceutical
preparations for medical laboratory use, namely,
preparations containing messenger RNA for preventing and
treating viruses and respiratory disorders
42
Pharmaceutical research and development; medical research
services; biotechnology research; scientific research for
medical purposes; design and development of medical
technology; design, engineering, research, and development
services in the field of nucleic acid sciences for medical
and scientific applications; providing medical and
scientific research in the fields of pharmaceuticals and
vaccines
44
Medical services; medical information; providing medical
information via a website
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 12. Juni 2023 | 2023/24 Gaz | NO | Ablehnung |
| 12. Mai 2023 | 2023/20 Gaz | LI | Ablehnung |
| 22. März 2023 | 2023/12 Gaz | CH | Ablehnung |
| 20. Juli 2022 | 2022/29 Gaz | AU | Ablehnung |
| 28. Oktober 2021 | 2022/17 Gaz | US | Eintragung |
ID: 141660204